CD38 Antibody – 174Yb
Validation: Each lot of conjugated antibody is quality control tested by staining tissue following the MIBI Staining Protocol optimized for the applicable tissue format with subsequent MIBIscope analysis using the appropriate positive and negative tissue field of views. These results are pathologist verified.
Recommended Usage: Human FFPE: 1:100 dilution.
For optimal results, the antibody should be titrated for each desired application.
MIBI technology: Learn more about MIBI™ Technology, a multiplex IHC technology with unmatched sensitivity and true subcellular resolution.
Shaji Kumar et al. Immunophenotyping in multiple myeloma and related plasma cell disorders. Best Pract Res Clin Haematol. 2010 Sep; 23(3): 433-451.
Chuan He et al. Prognostic significance of CD38 for chronic lymphocytic leukemia: a meta-analysis. Int J Clin Exp Med 2017; 10(3): 4305-4312.
* Conjugate tested on human tissue.